New Key Statistics Module, Z-Score and F-Score
SHSE:688319 Key Ratios
Market Cap ¥ M | 3,945.68 |
Enterprise Value ¥ M | 4,044.01 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | 43.19 |
Price/Book | 4.68 |
Price/Sales | 8.54 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) ¥ M | 489.00 |
EPS (TTM) ¥ | -0.10 |
Beneish M-Score | -2.52 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -180.00 |
EV-to-EBIT | -110.87 |
EV-to-EBITDA | -110.87 |
PEG | -- |
Shares Outstanding M | 405.93 |
Net Margin (%) | -7.96 |
Operating Margin % | -3.12 |
Pre-tax Margin (%) | -9.48 |
Quick Ratio | 1.65 |
Current Ratio | 1.83 |
ROA % (ttm) | -2.48 |
ROE % (ttm) | -4.30 |
ROIC % (ttm) | -1.74 |
Dividend Yield % | 0.39 |
Altman Z-Score | 3.51 |
SHSE:688319 Number of Guru Trades
SHSE:688319 Volume of Guru Trades
Gurus Latest Trades with SHSE:688319
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SHSE:688319 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Chengdu Olymvax Biopharmaceuticals Inc Insider Transactions
No Available Data